Conformis, Bodycad Laboratories Settle Patent Litigation

Conformis Inc.’s legal dispute with Bodycad Laboratories Inc., and Bodycad USA Corp. is finally over. 

The companies have resolved a 20-month patent dispute filed by Conformis in June 2021. 

“Conformis and Bodycad are pleased to have resolved their ongoing patent litigation. The companies have amicably agreed to an undisclosed amount for the dismissal of all patent litigation between the companies along with a release and license to certain Conformis patents related to patient-specific instrumentation and knee implants,” according to a formal statement from Conformis.
 
Conformis accused both Bodycad and Exactech of infringing U.S. Patent Nos. 8,974,539, 9,387,079, 7,799,077, 8,077,950, 8,638,998, and 9,180,015. The company in its complaint specifically cited Bodycad’s Reflex Uni unicondylar knee replacement and software, for replacing a single compartment of an arthritic knee, and Bodycad’s Fine Osteotomy patient-specific surgical guide and plate, for a knee osteotomy procedure where either the tibia or femur is cut and then reshaped to relieve pressure on the knee joint. Exactech had agreed to be the U.S. distributor for Bodycad’s Reflex Uni system under the name Truliant Reflex Uni.
 
Founded in 2004, Conformis is a medical technology company with a product portfolio ofg fully personalized solutions and data-informed, standardized solutions that combine many benefits of personalization with the convenience and flexibility of an off-the-shelf system. Conformis’ sterile, just-in-time, Surgery-in-a-Box delivery system is available with all of its implants and personalized, single-use instruments. Conformis owns or exclusively in-licenses issued patents and pending patent applications that cover personalized implants and patient-specific instrumentation for all major joints.
 
Bodycad is a Canadian company that developed proprietary software that provides specific design plans and personalized restorations based on the precise anatomical specifications of patients.